Abbott Laboratories Cash Flow from Operating Activities 2010-2025 | ABT
Abbott Laboratories cash flow from operating activities for the twelve months ending June 30, 2025 was $18.650B, a 25.55% increase year-over-year.
- Abbott Laboratories annual cash flow from operating activities for 2024 was $8.558B, a 17.86% increase from 2023.
- Abbott Laboratories annual cash flow from operating activities for 2023 was $7.261B, a 24.21% decline from 2022.
- Abbott Laboratories annual cash flow from operating activities for 2022 was $9.581B, a 9.04% decline from 2021.